CSI Market
Sign In | Register

Ngm Biopharmaceuticals Inc (NGM) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access NGM Annual Balance Sheets →
Reviewing balance sheet figures over time helps illustrate how Ngm Biopharmaceuticals Inc manages its resources, obligations, and shareholder equity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2023)
(Sep 30 2023) (Jun 30 2023) (Mar 31 2023) (Dec 31 2022)
Assets
Cash & cash equivalent55.82
Short-term Investments, Total88.37
Cash & Short-term Investments143.00
Accounts receivable0.06
Accounts Receivable, Related Parties, Current0.00
Other Current Assets3.00
Prepaid Expense And Other Assets Current9.20
Total Current Assets156.44
Equipment/Property/Plant Net7.03
Other Assets, Noncurrent3.00
Operating Lease Right Of Use Asset-
Restricted Cash Noncurrent2.46
Total Assets168.87
Liabilities
Accounts Payable, Current AC2.98
Accrued Liabilities, Current AC17.10
Other Liabilities, Current0.00
Total Current Liabilities20.08
Total Long-term Debt0.00
Other liabilities, Noncurrent0.15
Operating Lease Liability Current-
Total Liabilities20.23
Stockholders' Equity
Common Stock Value0.08
Additional Paid In Capital Common Stock872.55
Retained Earnings / Accumulated Deficit-724.01
Other Equity0.02
Common Stockholder's Equity148.64
Total Stockholder's Equity148.64
Liabilities & Stockholder's Equity168.87
4 historic quarters locked

Sign in to unlock the full Ngm Biopharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Ngm Biopharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20231231)
  • Filed with the SEC: March 11, 2024
  • Source: ngm-20231231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-24-010232

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.